| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |